BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21514534)

  • 21. The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy.
    You D; Jeong IG; Ahn JH; Lee DH; Lee JL; Hong JH; Ahn H; Kim CS
    J Urol; 2011 Jan; 185(1):54-9. PubMed ID: 21074811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors for chronic kidney disease after curative surgery in patients with small renal tumors.
    Jeon HG; Jeong IG; Lee JW; Lee SE; Lee E
    Urology; 2009 Nov; 74(5):1064-8. PubMed ID: 19758688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A retrospective study comparing the clinical efficacy of laparoscopic cryoablation and partial nephrectomy for renal cell carcinoma].
    Lian HB; Guo HQ; Gan WD; Li XG; Yan X; Zhang SW; Qu F; Yao LF; Zhang GT
    Zhonghua Wai Ke Za Zhi; 2010 Jun; 48(11):834-7. PubMed ID: 21163052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
    Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
    J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-portal access laparoscopic radical nephrectomy for renal cell carcinoma in transplant patients: the first experience.
    Greco F; Wagner S; Hoda MR; Weigand K; Inferrera A; Fornara P
    Eur Urol; 2011 Jun; 59(6):1060-4. PubMed ID: 20965647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of percutaneous needle biopsy in differentiation of renal tumors.
    Izumi K; Narimoto K; Sugimoto K; Kobori Y; Maeda Y; Mizokami A; Koh E; Yamada T; Yano S; Namiki M
    Jpn J Clin Oncol; 2010 Nov; 40(11):1081-6. PubMed ID: 20601495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bilateral radical nephrectomy and kidney transplantation as treatment for asynchronous bilateral renal cell carcinoma. A case report].
    Rodríguez-Covarrubias F; Gabilondo-Navarro F
    Gac Med Mex; 2006; 142(1):67-9. PubMed ID: 16548295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
    di Capua Sacoto C; Luján Marco S; Bahilo Mateu P; Budía Alba A; Pontones Moreno JL; Jiménez Cruz JF
    Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An unusual renal mass after partial nephrectomy for renal cell carcinoma.
    Jones J; Shah J; Morris S; Gordon EM; Patel U; Corbishley CM
    J Urol; 1999 Mar; 161(3):913-4. PubMed ID: 10022714
    [No Abstract]   [Full Text] [Related]  

  • 30. A national study of kidney graft tumor treatments: Toward ablative therapy.
    Guleryuz K; Doerfler A; Codas R; Coffin G; Hubert J; Lechevallier E; Tillou X;
    Surgery; 2016 Jul; 160(1):237-244. PubMed ID: 27032620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse renal outcomes in subjects undergoing nephrectomy for renal tumors: a population-based analysis.
    Klarenbach S; Moore RB; Chapman DW; Dong J; Braam B
    Eur Urol; 2011 Mar; 59(3):333-9. PubMed ID: 21109345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laparoscopic nephrectomy, ex vivo partial nephrectomy followed by allograft renal transplantation.
    Whitson JM; Stackhouse GB; Freise CE; Meng MV; Stoller ML
    Urology; 2007 Nov; 70(5):1007.e1-3. PubMed ID: 18068465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for renal dysfunction after nephrectomy in renal cell carcinomas.
    Xu Y; Wu B
    J Surg Res; 2011 Mar; 166(1):e53-7. PubMed ID: 21176917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal cell carcinoma in renal transplant patients.
    Ianhez LE; Lucon M; Nahas WC; Sabbaga E; Saldanha LB; Lucon AM; Srougi M
    Urology; 2007 Mar; 69(3):462-4. PubMed ID: 17382145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laparoscopic radical versus partial nephrectomy for tumors >4 cm: intermediate-term oncologic and functional outcomes.
    Simmons MN; Weight CJ; Gill IS
    Urology; 2009 May; 73(5):1077-82. PubMed ID: 19394509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephron-sparing surgery for de novo renal cell carcinoma in a 19-year-old transplanted kidney.
    De Simone P; Antonacci V; Rosa F; Verzaro R
    Transplantation; 2004 Feb; 77(3):478. PubMed ID: 14966434
    [No Abstract]   [Full Text] [Related]  

  • 37. Renal cell cancer: radical nephrectomy.
    Wotkowicz C; Libertino JA
    BJU Int; 2007 May; 99(5 Pt B):1231-8. PubMed ID: 17441916
    [No Abstract]   [Full Text] [Related]  

  • 38. Xanthogranulomatous pseudotumor after partial nephrectomy for renal cell carcinoma.
    Horinaga M; Nakashima J; Masuda T; Nagata H; Mukai M; Akatsuka S; Jitsukawa S
    J Urol; 2000 Oct; 164(4):1297. PubMed ID: 10992387
    [No Abstract]   [Full Text] [Related]  

  • 39. Editorial comment to postoperative renal function after partial nephrectomy for renal cell carcinoma in patients with pre-existing chronic kidney disease: a comparison with radical nephrectomy.
    Nohara T
    Int J Urol; 2011 Jun; 18(6):477. PubMed ID: 21599761
    [No Abstract]   [Full Text] [Related]  

  • 40. Partial nephrectomy for renal cell carcinoma in an allograft kidney 15 years after transplantation.
    Kim JY; Ruckle HC; Ramin SA
    J Urol; 2001 Apr; 165(4):1205. PubMed ID: 11257674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.